Korea Investment CORP lifted its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 6.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 483,639 shares of the medical research company’s stock after buying an additional 30,744 shares during the quarter. Korea Investment CORP owned 0.12% of Thermo Fisher Scientific worth $84,380,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. BB&T Securities LLC increased its holdings in Thermo Fisher Scientific by 4.4% during the 1st quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock worth $13,798,000 after purchasing an additional 3,819 shares during the last quarter. Toronto Dominion Bank increased its holdings in Thermo Fisher Scientific by 53.5% during the 1st quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock worth $16,450,000 after purchasing an additional 37,307 shares during the last quarter. IBM Retirement Fund increased its holdings in Thermo Fisher Scientific by 117.7% during the 2nd quarter. IBM Retirement Fund now owns 9,537 shares of the medical research company’s stock worth $1,860,000 after purchasing an additional 5,157 shares during the last quarter. Advisors Asset Management Inc. increased its holdings in Thermo Fisher Scientific by 1.1% during the 1st quarter. Advisors Asset Management Inc. now owns 66,308 shares of the medical research company’s stock worth $10,185,000 after purchasing an additional 735 shares during the last quarter. Finally, Cornerstone Investment Partners LLC increased its holdings in Thermo Fisher Scientific by 41.7% during the 2nd quarter. Cornerstone Investment Partners LLC now owns 421,541 shares of the medical research company’s stock worth $73,546,000 after purchasing an additional 123,954 shares during the last quarter. Institutional investors and hedge funds own 83.52% of the company’s stock.

Shares of Thermo Fisher Scientific Inc (TMO) opened at 191.47 on Thursday. The company has a market capitalization of $74.70 billion, a P/E ratio of 33.36 and a beta of 1.05. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $194.30. The stock has a 50 day moving average price of $178.97 and a 200-day moving average price of $169.99.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.27 by $0.03. The firm had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company’s revenue for the quarter was up 10.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.03 EPS. Equities research analysts predict that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 annualized dividend and a yield of 0.31%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.45%.

In other Thermo Fisher Scientific news, Director Jim P. Manzi sold 11,318 shares of the company’s stock in a transaction that occurred on Friday, August 18th. The stock was sold at an average price of $172.94, for a total value of $1,957,334.92. Following the completion of the transaction, the director now owns 38,757 shares of the company’s stock, valued at approximately $6,702,635.58. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Peter E. Hornstra sold 3,894 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total value of $721,090.92. Following the completion of the transaction, the vice president now directly owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The disclosure for this sale can be found here. In the last ninety days, insiders sold 22,738 shares of company stock valued at $4,021,512. Insiders own 0.49% of the company’s stock.

WARNING: “Korea Investment CORP Has $84.38 Million Position in Thermo Fisher Scientific Inc (TMO)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/09/14/korea-investment-corp-has-84-38-million-position-in-thermo-fisher-scientific-inc-tmo.html.

Several research firms have issued reports on TMO. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 price objective on the stock in a report on Thursday, September 7th. Cleveland Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a report on Thursday, July 20th. Argus restated a “buy” rating on shares of Thermo Fisher Scientific in a report on Tuesday, August 22nd. They noted that the move was a valuation call. Morgan Stanley restated an “overweight” rating and set a $220.00 price objective on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Finally, BidaskClub downgraded Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. Two research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Thermo Fisher Scientific has a consensus rating of “Buy” and an average target price of $193.19.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.